WASHINGTON, December 15, 2020 — Senate health committee Chairman Lamar Alexander (R-Tenn.) Tuesday released the following statement on the Food and Drug Administration’s approval of Ellume’s new over-the-counter, at-home diagnostic COVID-19 test:
Alexander and Senate health appropriations committee Chairman Roy Blunt (R-Mo.) led an effort in April to pass funding for the competitive “Shark Tank” at NIH so it could work in coordination with the Biomedical Advanced Research and Development Authority (BARDA) and the private sector to fast track new technologies designed to produce tens of millions of tests.